General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
IPO
Common Stock
Private Placement
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Income) Loss Net of Income Taxes
IPO
Private Placement
Total
Balance at Dec. 31, 2017     $ 140         $ 280,051 $ 8,004       $ 288,195
Balance (in shares) at Dec. 31, 2017     139,528                    
Foreign currency translation adjustment                   $ 3     3
Stock-based compensation expense               1,442         1,442
Common stock issued under employee purchase plan               100         100
Common stock issued under employee purchase plan (in shares)     50                    
Common stock issued upon exercise of stock options               7         $ 7
Common stock issued upon exercise of stock options (in shares)     2                   2
Common stock issued upon vesting of restricted stock units (in shares)     38                    
Net income (loss)                 3,177       $ 3,177
Balance at Dec. 31, 2018     $ 140         281,600 11,181 3     292,924
Balance (in shares) at Dec. 31, 2018     139,618                    
Foreign currency translation adjustment                         (67)
Stock-based compensation expense               1,680         1,680
Common stock issued upon exercise of stock options               177         $ 177
Common stock issued upon exercise of stock options (in shares)     65                   65
Common stock issued upon vesting of restricted stock units (in shares)     38                    
Net income (loss)                 23,307       $ 23,307
Balance at Dec. 31, 2019     $ 140         283,457 34,488 (67)     318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                   (153)     (153)
Stock-based compensation expense               802         802
Common stock issued upon exercise of stock options               70         70
Common stock issued upon exercise of stock options (in shares)     32                    
Net income (loss)                 2,440       2,440
Balance at Mar. 31, 2020     $ 140         284,329 36,928 (220)     321,177
Balance (in shares) at Mar. 31, 2020     139,753                    
Balance at Dec. 31, 2019     $ 140         283,457 34,488 (67)     318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                         488
Net income (loss)                         12,323
Balance at Sep. 30, 2020     $ 140         287,825 46,811 421     335,197
Balance (in shares) at Sep. 30, 2020     139,935                    
Balance at Dec. 31, 2019     $ 140         283,457 34,488 (67)     318,018
Balance (in shares) at Dec. 31, 2019     139,721                    
Foreign currency translation adjustment                   1,078     1,078
Stock-based compensation expense               5,984         5,984
Common stock issued under employee purchase plan               424         424
Common stock issued under employee purchase plan (in shares)     61                    
Common stock issued upon exercise of stock options               780         $ 780
Common stock issued upon exercise of stock options (in shares)     255                   254
Common stock issued upon vesting of restricted stock units (in shares)     185                    
Net income (loss)                 20,453       $ 20,453
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Balance at Mar. 31, 2020     $ 140         284,329 36,928 (220)     321,177
Balance (in shares) at Mar. 31, 2020     139,753                    
Foreign currency translation adjustment                   231     231
Stock-based compensation expense               1,140         1,140
Common stock issued upon exercise of stock options               51         51
Common stock issued upon exercise of stock options (in shares)     58                    
Net income (loss)                 4,078       4,078
Balance at Jun. 30, 2020     $ 140         285,520 41,006 11     326,677
Balance (in shares) at Jun. 30, 2020     139,811                    
Foreign currency translation adjustment                   410     410
Stock-based compensation expense               1,619         1,619
Common stock issued under employee purchase plan               423         423
Common stock issued under employee purchase plan (in shares)     61                    
Common stock issued upon exercise of stock options               263         263
Common stock issued upon exercise of stock options (in shares)     44                    
Common stock issued upon vesting of restricted stock units (in shares)     19                    
Net income (loss)                 5,805       5,805
Balance at Sep. 30, 2020     $ 140         287,825 46,811 421     335,197
Balance (in shares) at Sep. 30, 2020     139,935                    
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                   (799)     (799)
Stock-based compensation expense               2,538         2,538
Common stock issued upon exercise of stock options               538         538
Common stock issued upon exercise of stock options (in shares)     180                    
Net income (loss)                 5,644       5,644
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                         $ (141)
Common stock issued upon exercise of stock options (in shares)                         1,710
Net income (loss)                         $ 1,000
Balance at Sep. 30, 2021     $ 159   $ (1,802)     677,588 55,941 870     732,756
Balance (in shares) at Sep. 30, 2021     158,524   50                
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Foreign currency translation adjustment                   355     355
Stock-based compensation expense               4,714         4,714
Common stock issued upon exercise of stock options     $ 2         2,907         2,909
Common stock issued upon exercise of stock options (in shares)     871                    
Common stock issued upon vesting of restricted stock units (in shares)     217                    
Conversion of Series A preferred stock to common stock in connection with initial public offering     $ 5 $ (610) $ 260,686     (260,081)          
Conversion of Series A preferred stock to common stock (in shares)     5,190 (61,006) (15,146)                
Issuance of stock $ 10 $ 1       $ 269,380 $ 29,999       $ 269,390 $ 30,000  
Issuance of stock (in shares) 9,977 1,111                      
Net income (loss)                 (12,568)       (12,568)
Balance at Jun. 30, 2021     $ 158         670,674 48,017 567     719,416
Balance (in shares) at Jun. 30, 2021     157,768                    
Foreign currency translation adjustment                   303     303
Shares repurchased for settlement of employee tax withholdings         $ (1,802)               (1,802)
Shares repurchased for settlement of employee tax withholdings (in shares)         50                
Stock-based compensation expense               4,848         4,848
Common stock issued upon exercise of stock options     $ 1         2,066         2,067
Common stock issued upon exercise of stock options (in shares)     651                    
Common stock issued upon vesting of restricted stock units (in shares)     105                    
Net income (loss)                 7,924       7,924
Balance at Sep. 30, 2021     $ 159   $ (1,802)     $ 677,588 $ 55,941 $ 870     $ 732,756
Balance (in shares) at Sep. 30, 2021     158,524   50